In silico analysis of CDC73 gene revealing 11 novel SNPs with possible association to Hyperparathyroidism-Jaw Tumor syndrome

1Koikawa K, Okada Y, Mori H, Kawaguchi M, Uchino S, Tanaka Y. Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing. Intern Med. 2018;57(6):841-4.KoikawaKOkadaYMoriHKawaguchiMUchinoSTanakaYHyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic TestingIntern Med2018576841410.2169/internalmedicine.9509-17589152429225260Search in Google Scholar

2Mamedova E, Mokrysheva N, Vasilyev E, Petrov V, Pigarova E, Kuznetsov S, et al. Primary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndrome. Endocr Connect. 2017;6(8):557-65.MamedovaEMokryshevaNVasilyevEPetrovVPigarovaEKuznetsovSet alPrimary hyperparathyroidism in young patients in Russia: high frequency of hyperparathyroidism-jaw tumor syndromeEndocr Connect2017685576510.1530/EC-17-0126563306128870973Search in Google Scholar

3Sun W, Kuang XL, Liu YP, Tian LF, Yan XX, Xu W. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome. Sci Rep. 2017;7(1):15638.SunWKuangXLLiuYPTianLFYanXXXuWCrystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndromeSci Rep2017711563810.1038/s41598-017-15715-9568813029142233Search in Google Scholar

4Cavaco BM, Guerra L, Bradley KJ, Carvalho D, Harding B, Oliveira A, et al. Hyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 gene. J Clin Endocrinol Metab. 2004;89(4):1747-52.CavacoBMGuerraLBradleyKJCarvalhoDHardingBOliveiraAet alHyperparathyroidism-jaw tumor syndrome in Roma families from Portugal is due to a founder mutation of the HRPT2 geneJ Clin Endocrinol Metab200489417475210.1210/jc.2003-03101615070940Search in Google Scholar

5Muscarella LA, Turchetti D, Fontana A, Baorda F, Palumbo O, la Torre A, et al. Large deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesion. Oncotarget. 2018;9(29):20721-33.MuscarellaLATurchettiDFontanaABaordaFPalumboOla TorreAet alLarge deletion at the CDC73 gene locus and search for predictive markers of the presence of a CDC73 genetic lesionOncotarget2018929207213310.18632/oncotarget.25067594553329755684Search in Google Scholar

6Chen Y, Hu DY, Wang TT, Zhang R, Dong Q, Xu ZX, et al. CDC73 gene mutations in sporadic ossifying fibroma of the jaws. Diagn Pathol. 2016;11(1):91.ChenYHuDYWangTTZhangRDongQXuZXet alCDC73 gene mutations in sporadic ossifying fibroma of the jawsDiagn Pathol20161119110.1186/s13000-016-0532-0503463227658992Search in Google Scholar

7Newey PJ, Bowl MR, Cranston T, Thakker RV. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Hum Mutat. 2010;31(3):295-307.NeweyPJBowlMRCranstonTThakkerRVCell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumorsHum Mutat201031329530710.1002/humu.2118820052758Search in Google Scholar

8Parfitt J, Harris M, Wright JM, Kalamchi S. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review. J Oral Maxillofac Surg. 2015;73(1):194 e1-9.ParfittJHarrisMWrightJMKalamchiSTumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology reviewJ Oral Maxillofac Surg2015731194e1910.1016/j.joms.2014.09.00825511968Search in Google Scholar

9Redwin Dhas MP, Karthiga KS, Tatu JE, Eugenia SJ. Hyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous Features. Ethiop J Health Sci. 2017;27(3):309-13.RedwinDhas MPKarthigaKSTatuJEEugeniaSJHyper Parathyroidisim Jaw Tumor Syndrome: A Rare Condition of Incongruous FeaturesEthiop J Health Sci20172733091310.4314/ejhs.v27i3.14561500329217931Search in Google Scholar

10Pazienza V, la Torre A, Baorda F, Alfarano M, Chetta M, Muscarella LA, et al. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene. PLoS One. 2013;8(12):e82292.PazienzaVla TorreABaordaFAlfaranoMChettaMMuscarellaLAet alIdentification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 genePLoS One2013812e8229210.1371/journal.pone.0082292385538624340015Search in Google Scholar

11Piciu D, Piciu A, Barbus E, Pestean C, Larg MI, Fetica B. Primary hyperparathyroidism-jaw tumor syndrome: a confusing and forgotten diagnosis. Clujul Med. 2016;89(4):555-8.PiciuDPiciuABarbusEPesteanCLargMIFeticaBPrimary hyperparathyroidism-jaw tumor syndrome: a confusing and forgotten diagnosisClujul Med2016894555810.15386/cjmed-638511149827857527Search in Google Scholar

12Wasserman JD, Tomlinson GE, Druker H, Kamihara J, Kohlmann WK, Kratz CP, et al. Multiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. Clin Cancer Res. 2017;23(13):e123-e32.WassermanJDTomlinsonGEDrukerHKamiharaJKohlmannWKKratzCPet alMultiple Endocrine Neoplasia and Hyperparathyroid-Jaw Tumor Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in ChildhoodClin Cancer Res20172313e123e3210.1158/1078-0432.CCR-17-0548554788928674121Search in Google Scholar

13Aldred MJ, Talacko AA, Savarirayan R, Murdolo V, Mills AE, Radden BG, et al. Dental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(2):212-8.AldredMJTalackoAASavarirayanRMurdoloVMillsAERaddenBGet alDental findings in a family with hyperparathyroidism-jaw tumor syndrome and a novel HRPT2 gene mutationOral Surg Oral Med Oral Pathol Oral Radiol Endod20061012212810.1016/j.tripleo.2005.06.01116448924Search in Google Scholar

14Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet. 2002;32(4):676-80.CarptenJDRobbinsCMVillablancaAForsbergLPresciuttiniSBailey-WilsonJet alHRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndromeNat Genet20023246768010.1038/ng104812434154Search in Google Scholar

15Panicker LM, Zhang JH, Dagur PK, Gastinger MJ, Simonds WF. Defective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndrome. Endocr Relat Cancer. 2010;17(2):513-24.PanickerLMZhangJHDagurPKGastingerMJSimondsWFDefective nucleolar localization and dominant interfering properties of a parafibromin L95P missense mutant causing the hyperparathyroidism-jaw tumor syndromeEndocr Relat Cancer20101725132410.1677/ERC-09-0272309845320304979Search in Google Scholar

16Guarnieri V, Seaberg RM, Kelly C, Jean Davidson M, Raphael S, Shuen AY, et al. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family. BMC Med Genet. 2017;18(1):83.GuarnieriVSeabergRMKellyCJeanDavidson MRaphaelSShuenAYet alLarge intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome familyBMC Med Genet20171818310.1186/s12881-017-0445-0554355128774260Search in Google Scholar

17Mele M, Rolighed L, Jespersen M, Rejnmark L, Christiansen P. Recurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor Syndrome. Int J Endocrinol Metab. 2016;14(2):e35424.MeleMRolighedLJespersenMRejnmarkLChristiansenPRecurrence of Hyperparathyroid Hypercalcemia in a Patient With the HRPT-2 Mutation and a Previous Parathyroid Carcinoma in Hyperparathyroidism-Jaw Tumor SyndromeInt J Endocrinol Metab2016142e3542410.5812/ijem.35424503577427679651Search in Google Scholar

18Vamathevan J, Birney E. A Review of Recent Advances in Translational Bioinformatics: Bridges from Biology to Medicine. Yearbook of medical informatics. 2017;26(1):178-87.VamathevanJBirneyEA Review of Recent Advances in Translational Bioinformatics: Bridges from Biology to MedicineYearbook of medical informatics20172611788710.15265/IY-2017-017623922629063562Search in Google Scholar

19Ciuffi S, Cianferotti L, Nesi G, Luzi E, Marini F, Giusti F, et al. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity. Endocr J. 2019.CiuffiSCianferottiLNesiGLuziEMariniFGiustiFet alCharacterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosityEndocr J201910.1507/endocrj.EJ18-038730799315Search in Google Scholar

20Rubinstein JC, Majumdar SK, Laskin W, Lazaga F, Prasad ML, Carling T, et al. Hyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 Deletion. J Endocr Soc. 2017;1(7):926-30.RubinsteinJCMajumdarSKLaskinWLazagaFPrasadMLCarlingTet alHyperparathyroidism-Jaw Tumor Syndrome Associated With Large-Scale 1q31 DeletionJ Endocr Soc2017179263010.1210/js.2016-1089568664529264543Search in Google Scholar

21Sim N-L, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC.SimN-LKumarPHuJHenikoffSSchneiderGNg PCSearch in Google Scholar

22Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging mis-sense mutations. Nature methods. 2010;7(4):248-9.AdzhubeiIASchmidtSPeshkinLRamenskyVEGerasimovaABorkPet alA method and server for predicting damaging mis-sense mutationsNature methods201074248910.1038/nmeth0410-248285588920354512Search in Google Scholar

23Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the Functional Effect of Amino Acid Substitutions and Indels. PLOS ONE. 2012;7(10):e46688.ChoiYSimsGEMurphySMillerJRChanAPPredicting the Functional Effect of Amino Acid Substitutions and IndelsPLOS ONE2012710e4668810.1371/journal.pone.0046688346630323056405Search in Google Scholar

24Hecht M Fau - Bromberg Y, Bromberg Y Fau - Rost B, Rost B. Better prediction of functional effects for sequence variants. (1471-2164 (Electronic)).HechtMFau - Bromberg Y, Bromberg Y Fau - Rost B, Rost B. Better prediction of functional effects for sequence variants(1471-2164 (Electronic))Search in Google Scholar

25Capriotti E, Martelli PL, Fariselli P, Casadio R. Blind prediction of deleterious amino acid variations with SNPs&GO. (1098-1004 (Electronic)).CapriottiEMartelliPLFariselliPCasadioRBlind prediction of deleterious amino acid variations with SNPs&GO. (1098-1004 (Electronic))Search in Google Scholar

26López-Ferrando V, Gazzo A, de la Cruz X, Orozco M, Gelpí JL. PMut: a web-based tool for the annotation of pathological variants on proteins, 2017 update. Nucleic acids research. 2017;45(W1):W222-W8.López-FerrandoVGazzoAdela Cruz XOrozcoMGelpíJLPMut: a web-based tool for the annotation of pathological variants on proteins2017 update. Nucleic acids research201745W1W222W810.1093/nar/gkx313579383128453649Search in Google Scholar

27Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic acids research. 2005;33(Web Server issue):W306-W10.CapriottiEFariselliPCasadioRI-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structureNucleic acids research200533Web Server issueW306W1010.1093/nar/gki375116013615980478Search in Google Scholar

28Warde-Farley D, Donaldson Sl Fau - Comes O, Comes O Fau - Zuberi K, Zuberi K Fau - Badrawi R, Badrawi R Fau - Chao P, Chao P Fau - Franz M, et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. (1362-4962 (Electronic)).Warde-FarleyDDonaldsonSl Fau - Comes OComesO Fau - Zuberi KZuberiK Fau - Badrawi RBadrawiR Fau - Chao PChaoP Fau - Franz Met alThe GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function(1362-4962 (Electronic))Search in Google Scholar

29Venselaar H, Te Beek Ta Fau - Kuipers RKP, Kuipers Rk Fau - Hekkelman ML, Hekkelman Ml Fau - Vriend G, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. (1471-2105 (Electronic)).VenselaarHTe Beek Ta Fau - Kuipers RKP, Kuipers Rk Fau - Hekkelman ML, Hekkelman Ml Fau - Vriend G, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. (1471-2105 (Electronic))Search in Google Scholar

30Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, et al. The human genome browser at UCSC. Genome Res. 2002;12(6):996-1006.KentWJSugnetCWFureyTSRoskinKMPringleTHZahlerAMet alThe human genome browser at UCSCGenome Res2002126996100610.1101/gr.22910218660412045153Search in Google Scholar

31Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al.TateJGBamfordSJubbHCSondkaZBeareDMBindalNet alSearch in Google Scholar

32Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al.SherrySTWardMHKholodovMBakerJPhanLSmigielskiEMet alSearch in Google Scholar

33Deng N, Zhou H, Fan H, Yuan Y. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget. 2017;8(66):110635-49.DengNZhouHFanHYuanYSingle nucleotide polymorphisms and cancer susceptibilityOncotarget20178661106354910.18632/oncotarget.22372574641029299175Search in Google Scholar

34Khan IA, Mort M, Buckland PR, O’Donovan MC, Cooper DN, Chuzhanova NA. In silico discrimination of single nucleotide polymorphisms and pathological mutations in human gene promoter regions by means of local DNA sequence context and regularity. In silico biology. 2006;6(1-2):23-34.KhanIAMortMBucklandPRO’DonovanMCCooperDNChuzhanovaNAIn silico discrimination of single nucleotide polymorphisms and pathological mutations in human gene promoter regions by means of local DNA sequence context and regularityIn silico biology200661-22334Search in Google Scholar

35Mustafa MI, Mohammed ZO, Murshed NS, Elfadol NM, Abdelmoneim AH, Hassan MA. In Silico Genetics Revealing 5 Mutations in CEBPA Gene Associated With Acute Myeloid Leukemia. Cancer informatics. 2019;18:1176935119870817.MustafaMIMohammedZOMurshedNSElfadolNMAbdelmoneimAHHassanMAIn Silico Genetics Revealing 5 Mutations in CEBPA Gene Associated With Acute Myeloid LeukemiaCancer informatics201918117693511987081710.1177/1176935119870817677706131621694Search in Google Scholar

36Chiofalo MG, Sparaneo A, Chetta M, Franco R, Baorda F, Cinque L, et al. A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome. Cell Oncol (Dordr). 2014;37(4):281-8.ChiofaloMGSparaneoAChettaMFrancoRBaordaFCinqueLet alA novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndromeCell Oncol (Dordr)2014374281810.1007/s13402-014-0187-325113791Search in Google Scholar

37Guarnieri V, Seaberg RM, Kelly C, Jean Davidson M, Raphael S, Shuen AY, et al. Erratum to: Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family. BMC Med Genet. 2017;18(1):99.GuarnieriVSeabergRMKellyCJeanDavidson MRaphaelSShuenAYet alErratum to: Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome familyBMC Med Genet20171819910.1186/s12881-017-0459-7559691128903740Search in Google Scholar

38Sulaiman L, Haglund F, Hashemi J, Obara T, Nordenström J, Larsson C, et al. Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors. PloS one. 2012;7(9):e46325-e.SulaimanLHaglundFHashemiJObaraTNordenströmJLarssonCet alGenome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumorsPloS one201279:e46325-e10.1371/journal.pone.0046325346086923029479Search in Google Scholar

39Zheng H-C, Gong B-C, Zhao S. The clinicopathological and prognostic significances of CDC73 expression in cancers: a bioinformatics analysis. Oncotarget. 2017;8(56):95270-9.ZhengH-CGongB-CZhaoSThe clinicopathological and prognostic significances of CDC73 expression in cancers: a bioinformatics analysisOncotarget201785695270910.18632/oncotarget.20446570702029221126Search in Google Scholar